Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.
Cochrane Database Syst Rev. 2021 Mar 4;3:CD013348. doi: 10.1002/14651858.CD013348.pub2.
Cochrane Database Syst Rev. 2021.
PMID: 33661538
Review.